Clinical Trials Logo
  1. Home
  2. Clinically Isolated Syndrome
  3. NCT00819897

Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta — QUALICIS  

Clinically Isolated Syndrome Clinical Trial

Official title:
Longitudinal Study in Clinical Isolated Syndrome Patients Treated With Interferon Beta. Correlation With Cognitive Disorders and Quality of Life.

Clinical Trial Summary

The aim of this study is to evaluate the role of cognitive disorders and quality of life in patients with CIS, considered as high risk to develop an MS, treated with interferon Beta. This prospective observational study will include 120 patients, all treated and evaluated annually with neurological extensive examination, ophthalmologic screening (OCT, OF, VEP, VF), auto questionnaire about fatigue (musicol, ELIF), quality of life (SEP-59), and conventional MRI.

Clinical Trial Description

n/a

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00819897
Study type Observational
Source Centre Hospitalier Universitaire de Nice
Contact
Status Terminated
Phase N/A
Start date June 2008
Completion date June 2014
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Recruiting NCT03979391 - Isoelectric Focusing of Tears in Children With Radiologically Isolated or Clinically Isolated Syndrome N/A
Completed NCT02549703 - Mitochondrial Dysfunction and Disease Progression
Recruiting NCT03541226 - Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)
Active, not recruiting NCT04998851 - A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab Phase 4
Recruiting NCT05277740 - Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis
Recruiting NCT03004079 - Clinical Importance of Glucose Regulation in Relapsing MS
Completed NCT02043964 - Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion N/A
Completed NCT00287079 - A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome Phase 3
Terminated NCT04599023 - Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System
Completed NCT01728922 - Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome Phase 1/Phase 2
Completed NCT01737372 - A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis N/A
Terminated NCT00595920 - Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis Phase 2
Recruiting NCT05204459 - MS-ResearchBiomarkerS
Completed NCT04705610 - Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography N/A
Recruiting NCT03610139 - Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients N/A
Active, not recruiting NCT04009005 - Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis N/A
Not yet recruiting NCT06280755 - Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Completed NCT03872583 - Understanding Magnetic Resonance Imaging in Multiple Sclerosis N/A
Not yet recruiting NCT06274671 - Glymphatic MRI in Clinically Isolated Syndrome